• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [23538 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2010     Medical Advisory Secretariat (MAS) Non-invasive cardiac imaging technologies for the assessment of myocardial viability
2010     Andalusian Health Technology Assessment Area (AETSA) [Deep brain stimulation in the treatment of depressive and obsessive-complusive disorders]
2010     NIHR Health Technology Assessment programme Golimumab for the treatment of rheumatoid arthritis after failure of previous disease-modifying antirheumatic drugs: a single technology appraisal
2010     Basque Office for Health Technology Assessment (OSTEBA) [Integrated intra and extra-hospital approach to conduct disorders in adolescence]
2010     NIHR Health Technology Assessment programme School-linked sexual health services for young people (SSHYP): a survey and systematic review concerning current models, effectiveness, cost-effectiveness and research opportunities
2010     NIHR Health Technology Assessment programme Pazopanib for the first line treatment of patients with advanced and/or metastatic renal cell carcinoma: a single technology appraisal
2010     NIHR Health Technology Assessment programme Group cognitive behavioural therapy for postnatal depression: a systematic review of clinical effectiveness, cost effectiveness and value of information analyses
2010     NIHR Health Technology Assessment programme Vinflunine for the second line treatment of transitional cell carcinoma of the urothelial tract
2010     Haute Autorite de sante (HAS) [Assessment of medical devices for home infusion]
2010     NIHR Health Technology Assessment programme Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphoma
2010     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation
2010     NIHR Health Technology Assessment programme Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, costeffectiveness and economic analysis
2010     NIHR Health Technology Assessment programme Chemoprevention of colorectal cancer: systematic review and economic model
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ranolazine (Ranexa®)
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Atazanavir (Reyataz®) capsules
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Sildenafil citrate (Revatio®) solution
2010     Blue Cross Blue Shield Association (BCBS) Gene expression profiling in women with lymph-node-positive breast cancer to select adjuvant chemotherapy treatment
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tipranavir (Aptivus®) capsules
2010     Blue Cross Blue Shield Association (BCBS) Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment
2010     HAYES, Inc. Alair bronchial thermoplasty system (Asthmatx Inc.) for treatment of asthma
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tipranavir (Aptivus®) oral solution
2010     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Bariatric surgery in diabetic type 2 patients with CMI at or above 30 kg/m2]
2010     Blue Cross Blue Shield Association (BCBS) Special report: positron emission tomography for the indication of post-treatment surveillance of cancer
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Epoetin theta (Eporatio®)
2010     Blue Cross Blue Shield Association (BCBS) Low-level laser therapy for carpal tunnel syndrome and chronic neck pain
2010     HAYES, Inc. Autologous stem cell transplantation followed by nonmyeloablative allogeneic stem cell transplantation for treatment of multiple myeloma
2010     The Netherlands Organisation for Health Research and Development (ZonMw) [Transmural nutritional support]
2010     Blue Cross Blue Shield Association (BCBS) Radiofrequency ablation of nondysplastic or low-grade dysplastic barrett's esophagus
2010     Penn Medicine Center for Evidence-based Practice (CEP) Postpartum management of hypertensive disorders
2010     HAYES, Inc. Bayley scales of infant (and toddler) development testing (Pearson Education Inc.) for developmental delays in infants
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Olanzapine depot (ZypAdhera)
2010     The Swedish Council on Health Technology Assessment (SBU) Antibiotic prophylaxis in surgical interventions
2010     Penn Medicine Center for Evidence-based Practice (CEP) Calibration of computerized drug interaction alerts
2010     Institute for Clinical Effectiveness and Health Policy (IECS) Electrical stimulation for the treatment of headaches
2010     Penn Medicine Center for Evidence-based Practice (CEP) Albumin use in the healthcare setting
2010     HAYES, Inc. Brainstem Auditory Evoked Response (BAER) for assessment of brainstem dysfunction in patients with chiari malformations
2010     VA Technology Assessment Program (VATAP) Gadolinium-containing contrast agents for patients with renal disease
2010     Institute for Clinical Effectiveness and Health Policy (IECS) Tocilizumab for rheumatoid arthritis
2010     Penn Medicine Center for Evidence-based Practice (CEP) Prevention of catheter-associated venous thrombosis
2010     HAYES, Inc. Breast-Specific Gamma Imaging (BSGI) using the Dilon 6800 gamma camera (Dilon Technologies Inc.)
2010     Institute for Clinical Effectiveness and Health Policy (IECS) Digital dermoscopy in the diagnosis of melanoma
2010     Penn Medicine Center for Evidence-based Practice (CEP) Routine newborn monitoring immediately following birth
2010     HAYES, Inc. Chantix (Varenicline Tartrate) (Pfizer Inc.) for smoking cessation
2010     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Appropriate use of diagnostic imaging technologies in acute abdominal pain]
2010     Institute for Clinical Effectiveness and Health Policy (IECS) [Usefulness of kinesiotaping]
2010     Institute for Clinical Effectiveness and Health Policy (IECS) Citoreductive Surgery + Hypertermic Intraperitoneal Quimiotherapy for peritoneal carcinomatosis
2010     Penn Medicine Center for Evidence-based Practice (CEP) Pre-operative hair removal in different settings to decrease surgical site infections
2010     HAYES, Inc. ChloraPrep (CareFusion Corp.) for skin antisepsis
2010     Penn Medicine Center for Evidence-based Practice (CEP) Preventing catheter-related bloodstream infections in home infusion patients
2010     Institute for Clinical Effectiveness and Health Policy (IECS) Pandemic Influenza A Vaccine (H1N1)
2010     Penn Medicine Center for Evidence-based Practice (CEP) Care management
2010     Haute Autorite de sante (HAS) [High intensity focalized ultrasound for the treatment of localized prostate cancer]
2010     Penn Medicine Center for Evidence-based Practice (CEP) Permacol implants for hernia repair
2010     Institute for Clinical Effectiveness and Health Policy (IECS) Clofarabine for the treatment of adult leukemia and lymphoma
2010     Penn Medicine Center for Evidence-based Practice (CEP) Adapting Penn Medicine's inpatient services to meet the ACGME's proposed duty hour regulations
2010     HAYES, Inc. Entereg (Alvimopan) (Adolor Corp.) to reduce postoperative ileus
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Cetuximab (Erbitux®) for third-line treatment of patients with KRAS wild-type metastatic colorectal cancer
2010     Penn Medicine Center for Evidence-based Practice (CEP) Management of retroperitoneal bleeding in coronary catheterization patients
2010     Institute for Clinical Effectiveness and Health Policy (IECS) Chemoembolization of hepatocellular carcinoma with drug eluting beads (DC Beads)
2010     Penn Medicine Center for Evidence-based Practice (CEP) Management of central venous catheters in hemodialysis patients with bloodstream infections
2010     HAYES, Inc. E-tegrity test (Hologic Inc.; distributed by Sepal Reproductive Devices) for evaluation of uterine receptivity
2010     National Evidence-based Healthcare Collaborating Agency (NECA) [The disease burden of seasonal influenza and the effectiveness of seasonal influenza vaccination in Korea]
2010     Haute Autorite de sante (HAS) [Cardiac markers in coronary disease and heart failure in outpatient medicine]
2010     Penn Medicine Center for Evidence-based Practice (CEP) Guidelines for care after percutaneous coronary intervention (PCI)
2010     Institute for Clinical Effectiveness and Health Policy (IECS) [Percutaneous aortic valve replacement for aortic stenosis]
2010     Penn Medicine Center for Evidence-based Practice (CEP) Guidelines for warfarin use in orthopedic surgery patients
2010     HAYES, Inc. HE4 assay (Fujirebio Diagnostics Inc.) on the Architect platform (Abbott Diagnostics) for ovarian cancer monitoring
2010     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Cardiac resynchronization therapy. Economic evaluation]
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Epoetin alfa (Binocrit®)
2010     National Evidence-based Healthcare Collaborating Agency (NECA) [The survey and cross-sectional analysis of palliative radiotherapy for bone metastases to facilitate its proper use in cancer patients]
2010     Haute Autorite de sante (HAS) [Virtual colonoscopy: meta-analysis of diagnostic accuracy, indications and conditions of use]
2010     Penn Medicine Center for Evidence-based Practice (CEP) Transfusion thresholds for orthopedic surgery patients
2010     Penn Medicine Center for Evidence-based Practice (CEP) Silver coated dressings for prevention of surgical site infections in cardiac surgery patients
2010     HAYES, Inc. Inhaled nitric oxide for Acute Respiratory Distress Syndrome (ARDS) in adults
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Filgrastim (TevaGrastim®)
2010     National Evidence-based Healthcare Collaborating Agency (NECA) [Pain relief effects of injection therapy for patients with chronic back pain]
2010     Haute Autorite de sante (HAS) [Treatment of multiple missing teeth in adults with rare diseases by using implant-supported denture]
2010     Penn Medicine Center for Evidence-based Practice (CEP) Dexmedetomidine for sedation during intubation
2010     Penn Medicine Center for Evidence-based Practice (CEP) GI bleeding risks with celecoxib
2010     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Development and validation of methods for quality assessment of health technologies assessments reports : assessment of ethical issues in health technologies assessment]
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Filgrastim (Zarzio®)
2010     National Evidence-based Healthcare Collaborating Agency (NECA) [Health technology assessment for the effectiveness and safety of human placenta injections]
2010     Haute Autorite de sante (HAS) [Cervical length measurement with transvaginal ultrasonography to predict spontaneous preterm birth]
2010     Penn Medicine Center for Evidence-based Practice (CEP) Management of the second stage of labor
2010     Quality Improvement Scotland (NHS QIS ) A guide to synthesising qualitative research for researchers undertaking health technology assessments and systematic reviews
2010     Penn Medicine Center for Evidence-based Practice (CEP) CT for acute chest pain
2010     HAYES, Inc. Intraoperative Radiation Therapy (IORT) for colorectal cancer
2010     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Laparoscopic surgery in colorectal cancer : quality of life, psychological impact and patient satisfaction]
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Sildenafil (Revatio®) for the treatment of pulmonary arterial hypertension (WHO functional class II or III) to improve exercise capacity
2010     National Evidence-based Healthcare Collaborating Agency (NECA) [The evidence of korean guidelines for the use of lipid lowering agents: drug utilization review and outcomes research]
2010     Haute Autorite de sante (HAS) [Place of Breast MRI in the pre-treatment locoregional spread assessment of breast cancer]
2010     Penn Medicine Center for Evidence-based Practice (CEP) Transfusion thresholds for cardiovascular surgery patients
2010     Quality Improvement Scotland (NHS QIS ) Weight management programmes for adults
2010     Penn Medicine Center for Evidence-based Practice (CEP) Bleeding risks from celecoxib vs. non-selective NSAIDS in orthopedic surgery
2010     HAYES, Inc. Intraoperative Radiation Therapy (IORT) for pancreatic cancer
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Raltegravir (Isentress®) in combination with other antiretrovirals for the treatment of HIV-1 infection in adults
2010     National Evidence-based Healthcare Collaborating Agency (NECA) [Effectiveness of treatments for carcinomas of an unknown primary site]
2010     Penn Medicine Center for Evidence-based Practice (CEP) Urine drug screening in chronic pain patients on opioid therapy
2010     Quality Improvement Scotland (NHS QIS ) Portable bladder ultrasound scanners
2010     Penn Medicine Center for Evidence-based Practice (CEP) The use of bispectral index monitoring for patients receving therapeutic hypothermia